{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticholinesterase activity", "Antidiabetic activity", "Antioxidant activity", "Buchanania axillaris", "Hemidesmus indicus", "Phytochemical profile", "Rhus mysorensis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29499679", "DateCompleted": {"Year": "2018", "Month": "04", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "02"}], "Language": ["eng"], "ELocationID": ["77", "10.1186/s12906-018-2140-x"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "18", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Mar", "Day": "02"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.", "Pagination": {"StartPage": "77", "MedlinePgn": "77"}, "Abstract": {"AbstractText": ["Extensive epidemiological and clinical studies revealed that Alzheimer's Disease (AD) and Type 2 Diabetes Mellitus (T2D) are most likely to appear simultaneously in aged people as T2D is a major risk factor for AD. Therefore, development of potential multifunctional agents for dual therapy of AD and T2D has received much attention. Buchanania axillaris, Hemidesmus indicus and Rhus mysorensis have been used extensively in popular medicine. The present study was aimed at phytochemical profiling and evaluating multifunctional ability of titled plants in the AD and T2D dual therapy.", "Methanolic extracts and their derived fractions were evaluated for their inhibitory capacities against acetylcholinesterase (AChE) & butyrylcholinesterase (BuChE), and \u03b1- & \u03b2-glucosidase besides kinetic analysis of inhibition using methods of Elmann and Shibano, respectively. Antioxidant potency of active fractions was assessed by their DPPH and ABTS radical scavenging activities. Active fractions were tested by the MTT assay to verify cytotoxicity and neuroprotective ability in human nueroblastoma cell lines. Phytochemical screening was done with the aid of spectrophotometric methods.", "All the methanolic extracts of test plants (BAM, HIM, RMM) showed concentration dependent inhibitory activities against AChE, BuChE, \u03b1- and \u03b2-glucosidase enzymes. Subsequent fractionation and evaluation revealed that chloroform fractions BAC, HIC and RMC with IC<sub>50</sub> values of 12.29\u00b12.14, 9.94\u00b12.14, 16.65\u00b11.99 and 27.38\u00b11.24; 28.14\u00b10.9, 5.16\u00b10.22, 11.03\u00b10.5 and 87.64\u00b115.41; 41.35\u00b11.6, 15.86\u00b17.3, 26.04\u00b10.37 and 25.33\u00b10.3 were most prominent with regard to inhibition potential against AChE, BuChE, \u03b1- and \u03b2-glucosidase, respectively. Kinetic analysis of these active fractions proved that they disclosed mixed-type inhibition against AChE, BuChE, \u03b1- and \u03b2-glucosidase enzymes. In the MTT assay, active fractions BAC, HIC, RMC showed significant cell viability at high concentrations (400 \u03bcg). Moreover, in MTT assay, the active fractions displayed excellent neuroprotective effects against oxidative stress induced cell death and significant cell viability in SK N SH cells at all concentrations.", "The strong anticholinesterase, antiglucosidase, antioxidant and neuroprotective activities of methanolic extracts and their derived chloroform fractions indicate the potential of Buchanania axillaris, Hemidesmus indicus and Rhus mysorensis as multifunctional therapeutic remedies for the dual therapy of T2D and AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India."}], "LastName": "Penumala", "ForeName": "Mohan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India."}], "LastName": "Zinka", "ForeName": "Raveendra Babu", "Initials": "RB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India."}], "LastName": "Shaik", "ForeName": "Jeelan Basha", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, Andhra Pradesh, India."}], "LastName": "Mallepalli", "ForeName": "Suresh Kumar Reddy", "Initials": "SKR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, Andhra Pradesh, India."}], "LastName": "Vadde", "ForeName": "Ramakrishna", "Initials": "R"}, {"Identifier": ["0000-0002-6578-3232"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India. agdamu01@gmail.com."}], "LastName": "Amooru", "ForeName": "Damu Gangaiah", "Initials": "DG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}, {"RegistryNumber": "EC 3.2.1.-", "NameOfSubstance": "Glucosidases"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy", "enzymology", "genetics"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["drug therapy", "enzymology", "genetics"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Glucosidases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not Applicable CONSENT FOR PUBLICATION: Not Applicable COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alzheimer CJL. s disease. N Engl J Med. 2004;351:56\u201367. doi: 10.1056/NEJMra040223.", "ArticleIdList": ["10.1056/NEJMra040223", "15229308"]}, {"Citation": "Forstl H, Kurz A. 1999. Clinical features of Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. 2004;249:288\u2013290.", "ArticleIdList": ["10653284"]}, {"Citation": "Ali GC, Guerchet M, Wu YT, Prince M, Prina M. The global prevalence of dementia in World Alzheimer Report: The Global Impact of Dementia Alzheimer\u2019s Disease International. 2015. pp. 10\u201328."}, {"Citation": "Citron M. Alzheimer\u2019s disease: strategies for disease modification. Nat Rev Drug Discov. 2010;9:387\u2013398. doi: 10.1038/nrd2896.", "ArticleIdList": ["10.1038/nrd2896", "20431570"]}, {"Citation": "Melnikova I. Therapies for Alzheimer\u2019s disease. Nat Rev Drug Discov. 2007;6:341\u2013352. doi: 10.1038/nrd2314.", "ArticleIdList": ["10.1038/nrd2314", "17539055"]}, {"Citation": "Fal\u00e9 PLV, Lia AM, Luisa S, Haris PI. Interaction between Plectranthus barbatus herbal tea components and acetylcholinesterase: binding and activity studies. Food Funct. 2012; 3:1176\u20131184.", "ArticleIdList": ["22801419"]}, {"Citation": "Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. Acetylcholinesteraseaccelerates assembly of amyloid-beta-peptides into Alzheimer\u2019s fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996;16:881\u2013891. doi: 10.1016/S0896-6273(00)80108-7.", "ArticleIdList": ["10.1016/S0896-6273(00)80108-7", "8608006"]}, {"Citation": "Walsh R, Rockwood K, Martin E, Darvesh S. Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochim Biophys Acta. 2011;1810:1230\u20131235. doi: 10.1016/j.bbagen.2011.08.010.", "ArticleIdList": ["10.1016/j.bbagen.2011.08.010", "PMC3263522", "21872646"]}, {"Citation": "Mittal K, Deepshikha PK. \"Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review\", Diabetes & Metabolic Syndrome Clinical Research &Reviews, 2016; 144\u2013S149.", "ArticleIdList": ["26907971"]}, {"Citation": "Report on diabetes . Geneva. 2016. World Health Organization."}, {"Citation": "Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, DJr P. Cerebrospinal fluid and plasma insulin levelsin Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 1998;50:164\u2013168. doi: 10.1212/WNL.50.1.164.", "ArticleIdList": ["10.1212/WNL.50.1.164", "9443474"]}, {"Citation": "Chen YG, Li P, Yan R, Zhang XQ, Wang Y, Zhang XT, Ye WC, Zhang QW. \u03b1-Glucosidase inhibitory effect and simultaneous quantification of three major flavonoid glycosides in Microctis folium. Molecules. 2013;18:4221\u20134232. doi: 10.3390/molecules18044221.", "ArticleIdList": ["10.3390/molecules18044221", "PMC6270556", "23612474"]}, {"Citation": "Soumya D, Srilatha B. Late Stage Complications of Diabetes and Insulin Resistance. J Diabetes Metab. 2011;2(9):1000167."}, {"Citation": "Ebenezer A, Nyenwea TW, Jerkinsb GE, Umpierrezc Abbas E, Kitabchia. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.Metabolism. January. 2011; 60: 1\u201323.", "ArticleIdList": ["PMC3746516", "21134520"]}, {"Citation": "Giuseppe V, Stephanie JF, Ralph NM. The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease. 2015;84:22\u201338. doi: 10.1016/j.nbd.2015.04.008.", "ArticleIdList": ["10.1016/j.nbd.2015.04.008", "25926349"]}, {"Citation": "Butterfield DA, Di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta. 2014;1842:1693\u20131706. doi: 10.1016/j.bbadis.2014.06.010.", "ArticleIdList": ["10.1016/j.bbadis.2014.06.010", "PMC4125611", "24949886"]}, {"Citation": "Mittal K, Katare DP. Shared Links between Type 2 Diabetes Mellitus and Alzheimer\u2019s disease: A Review, Diabetes and Metabolic Syndrome:Clinical Research and Reviews. 2016.", "ArticleIdList": ["26907971"]}, {"Citation": "Tomomi F, Hiroshi I, Kaori I, Yumiko K, Toshio O. Effect of two \u03b1-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism. 2005;54:387\u2013390. doi: 10.1016/j.metabol.2004.10.004.", "ArticleIdList": ["10.1016/j.metabol.2004.10.004", "15736118"]}, {"Citation": "Rao RV, Descamps O, John V, Bredesen DE. Ayurvedic medicinal plants a review. Alzheimers Res Ther. 2012;4:22. doi: 10.1186/alzrt125.", "ArticleIdList": ["10.1186/alzrt125", "PMC3506936", "22747839"]}, {"Citation": "Ellman GL, Courtney KD, Andres V, Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Shibano M, Kitagawa S, Nakamura S, Akazawa N, Kusano G. Studies on the constituents of Broussonetiaspecies. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from BroussonetiakazinokiSieb. Chem. Pharm. Bull. 1997;45:700\u2013705. doi: 10.1248/cpb.45.700.", "ArticleIdList": ["10.1248/cpb.45.700", "9145506"]}, {"Citation": "Jeelan Basha S, Bhagath Kumar P, Mohan P, Kasi Viswanath K, Subba Rao D, Siddhartha E, M Manidhar D, Dinakara Rao A. Ramakrishna V. Damu AG. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. European Journal of Medicinal Chemistry. 2016; 10: 219\u2013232.", "ArticleIdList": ["26588065"]}, {"Citation": "Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26:1231\u20131237. doi: 10.1016/S0891-5849(98)00315-3.", "ArticleIdList": ["10.1016/S0891-5849(98)00315-3", "10381194"]}, {"Citation": "Sarikurkcu C, Arisoy K, Tepe B, Cakir A, Abali G, Mete E. Studies on the antioxidant activity of essential oil and different solvent extracts of Vitex agnus castus L. Fruits from Turkey. Food Chem. Toxicol. 2009;47(10):2479\u20132483. doi: 10.1016/j.fct.2009.07.005.", "ArticleIdList": ["10.1016/j.fct.2009.07.005", "19595732"]}, {"Citation": "Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdicphosphotungstic acid reagents. Am. J. Enol. Vitic. 1965;16:144\u2013158."}, {"Citation": "Roya K, Fatemeh G. Screening of total phenol and flavonoid content, antioxidant and antibacterial activities of the methanolic extracts of three Silene species from Iran. Intl. J. Agri. Crop Sci. 2013;5:305\u2013312."}, {"Citation": "Narayan Ghorai CS, Gucchait S, Kumar SS, Suman B. Estimation of total Terpenoids concentration in plant tissues using a monoterpen, Linalool as standard reagent. Protocol Exchange. 2012;005"}, {"Citation": "Shamsa F, Monsef H, Ghamooshi R, Verdian-rizi M. Spectrophotometric Determination of Total Alkaloids in Some Iranian Medicinal Plant. Thai. J. Pharm. Sci. 2008;32:17\u201320."}, {"Citation": "Rampa A, Bisi A, Belluti F, Gobbi S, Valenti P, Andrisano V, Cavrini V, Cavalli A, Recanatini M. acetylcholinesteraseinhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10- ylamine derivatives. Bioorg. Med. Chem. 2000;84:97\u2013506.", "ArticleIdList": ["10732965"]}, {"Citation": "Paz M, G\u00fallon P, F\u00e1tima Barroso M, Carvalho P, Domingues VF, Gomes M, Helena B, Elisane L, Delerue-Matos C. Brazilian fruit pulps as functional foods and additives: Evaluation of bioactive compounds. Food Chemistry. 2015;172:462\u2013468. doi: 10.1016/j.foodchem.2014.09.102.", "ArticleIdList": ["10.1016/j.foodchem.2014.09.102", "25442579"]}, {"Citation": "Baptista FI, Henriques AG, Silva AMS, Wiltfang J, Cruz e Silva OAB. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer\u2019s Disease. ACS Chem. Neurosci. 2014;5:83\u201392. doi: 10.1021/cn400213r.", "ArticleIdList": ["10.1021/cn400213r", "PMC3930994", "24328060"]}, {"Citation": "Pullaiah T. Encyclopedia of world medicinal plants.Vol 1. Regency publication; New Delhi. 2006:366\u20137."}, {"Citation": "Mohamed H, Ons M, Ellouz-Triki Y, Rayda S, Neji G, Nasri M. Chemical composition and antioxidant and radical-scavenging activities of Periploca laevigata root bark extracts. J. Sci Food & Agri. 2009;89(5):897\u2013905. doi: 10.1002/jsfa.3532.", "ArticleIdList": ["10.1002/jsfa.3532"]}, {"Citation": "Khare CP. Indian medicinal plant illustrated dictionary. Springer verlag Heidelberg. 2004:104\u20135."}, {"Citation": "Sakthivel K, Palani S, Santhosh Kalash R, Devi K, Senthi Kumar B. Phytoconstituents analysis by gc-ms,cardioprotective and antioxidant activity of buchanania axillaris against doxorubicin-induced cardio toxicity in albino rats. IJPSR. 2010; 1(1): 34\u2013 48."}, {"Citation": "Austin A. A Review on Indian sarsaparilla, Hemidesmus indicus (L.) R.Br. J. Biol. Sci. 2008;8(1):1\u201312. doi: 10.3923/jbs.2008.1.12.", "ArticleIdList": ["10.3923/jbs.2008.1.12"]}, {"Citation": "Lakshmi T, Rajendran R. Hemidesmus indicus commonly known as indian sarasaparilla- an update. Int. J Pharm Bio Sci. 2013;4:397\u2013404."}, {"Citation": "Mahsa Z, Syed B, Mehrdad Z. Effect of Hemidesmus indicus root extract on the blood glucose level in alloxan induced diabetic rats. J. Microbiol. Biotech. Res. 2013;3:64\u201367."}, {"Citation": "Sun B, Richardo-Da-Silvia JM, Spranger I. Critical factors of vanillin assay for catechins and proanthocyanidins. J. Agric. Food Chem. 1998;46:4267\u20134274. doi: 10.1021/jf980366j.", "ArticleIdList": ["10.1021/jf980366j"]}, {"Citation": "Kirthikar K, Basu BD. Indian medicinal plants, Vol 3, Periodical experts. New Delhi. 1985:1596\u20138."}, {"Citation": "Anonymous. The Ayurvedic Pharmacopoeia of India. 1st Edn. Ministry of Health and Acta. 1989. 1842:1693\u2013706."}, {"Citation": "Anonymous The Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products. Vol. 2, National Institute of Science Communication. New Delhi. 2001;817:236\u20132137."}, {"Citation": "Anonymous. Quality Standards of Indian Medicinal Plants. Vol. 2. Indian Council of Medical Research; New Delhi. 2005:119\u201328."}, {"Citation": "Sumona chakraborttya, Rachana choudhary, Hemidesmus indicus (anantmool) Rare herb of chhattisgarh. Indian. J. Sci. Res. 2014;4(1):89\u201393."}, {"Citation": "Mohammed Moideen M, Varghese R, Krishna Kumar E, Dhanapal CK. Wound Healing Activity of Ethanolic Extract Of Hemidesmus Indicus (Linn) R.Br Leaves In Rats. Research Journal of Pharmaceutical, Biological and Chemical. Sciences. 2011;2:643."}, {"Citation": "Madhavachetty K, Shivaraj K, Thulasirao K. Flowering plants of Chittoor district, Andhra Pradesh. Tirupathi. Students offset printers. 1st edition. 2008; 358."}, {"Citation": "Deepak Reddy G. Sree Kumar Reddy G, Surya Narayana Reddy A, Vamsi RP. Hepatoprotective activity of Rhus mysorensis against carbon tetrachloride induced hepatotoxicity in albino rats. International Journal of Pharmaceutical Sciences Review and Research. 2010;4:008."}, {"Citation": "Mohammed A, Rravishankar Rai V, Pradeep VSA. ntimicroboal and Phytochemical screening of Boswellia serrata Roxb., Rhus mysorensis Heyne, Strychnos Potatorum Linm.F.and Schefflera stellata Gaertn. Medicinal and aromatic plant science and Biotechnology. 2010;4:69\u201372."}, {"Citation": "Noorulla KD. Badru DMd, Janardhan N, Duraivel S, Evaluation of the hepatoprot ective activity of Rhus mysorensis in albino rats Indian Journal of Research in Pharmacy and. Biotechnology. 2014;2(4):1010\u20131014."}]}], "History": [{"Year": "2017", "Month": "5", "Day": "17"}, {"Year": "2018", "Month": "2", "Day": "21"}, {"Year": "2018", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["29499679", "PMC5834903", "10.1186/s12906-018-2140-x", "10.1186/s12906-018-2140-x"]}}]}